Industry News
GTG in third US licence deal
Melbourne-based Genetic Technologies has licensed its non-coding DNA patents to a third US genomics company, Perlegen Sciences, for about $1.6 million in cash and securities. [ + ]
Shedding light on the Big Bang
Scientists at the ANU have developed a technology that may be used to study the universe's most violent events - the Big Bang and exploding stars. Their research shows that 'squeezed' light could be used to improve the performance of gravitational wave detectors.
[ + ]Synchrotron seeking commercial director
The Australian Synchrotron Project has progressed to the stage where it requires a commercial director to develop commercial and policy frameworks. [ + ]
New doubts cast on adult stem cell potential
Researchers at Stanford University Medical Center in the US have reported that they failed in attempts to coax adult blood-forming stem cells in mice into forming tissues other than blood and immune cells. [ + ]
AusBiotech recruiting for French devices and diagnostics tour
Up to 20 AusBiotech members are being offered the chance to take part in a medical devices and diagnostics mission in France this November 4-8, under the auspices of the French-Australian Industrial Research (FAIR) program. [ + ]
Chemeq picks up the pace in South Africa
Perth-based company Chemeq has started its push to introduce its polymeric antimicrobial drug for prevention of colibacillosis in pigs into South Africa, the first country to approve the veterinary product. [ + ]
From footy to neuroscience: CogState branches out
A Melbourne company, whose test to measure cognitive abilities counts AFL teams among its customers, is branching out into biotech to develop neuroscience therapeutics. [ + ]
Panbio finds R&D leader in its own backyard
Medical diagnostics company Panbio has headhunted Prof Stuart Hazell, dean of the University of Southern Queensland's science faculty, as its vice-president for R&D. [ + ]
Griffith, Monash researchers behind new start-up
Two leading Australian scientists - Prof Mark von Itzstein and Prof Ross Coppel - have helped form a new company to deliver novel pharmaceuticals for use against drug-resistant bacteria. [ + ]
Biocomm names Canadian as chief operating officer
Melbourne-based life science commercialisation company Biocomm Services has appointed former Calgary Innovation Centre (CIC) executive director Lawrence Bremner as its new chief operating officer. [ + ]
MSAC decision disappoints Sirtex CEO
The chief executive of Sydney-based company Sirtex has expressed disappointment with the Medical Services Advisory Committee (MSAC) following its surprise rejection of a subsidy application for the company's liver cancer treatment. [ + ]
Monash IRD creates mouse model for neuro disease
Researchers at the Monash Institute of Reproduction and Development have succeeded in creating a transgenic mouse model for Kennedy disease, a neurodegenerative disease that affects approximately 1 in 50,000 men. [ + ]
Australian technology helps create triple-seeding soybeans
A soybean variety developed in collaboration with James Cook University could double yields for Vietnamese farmers.
[ + ]Former GroPep CEO Ballard launches angel fund
A new business angel network, BioAngels Inc, has been launched in Adelaide by former GroPep CEO John Ballard. [ + ]
Virax to extend trials for HIV/AIDS therapy
Melbourne-based immune therapies company Virax Holdings has announced an extension to its Phase I/IIA clinical trial to further assess the potential of its HIV/AIDS therapy. [ + ]
